[1] Kim DH,Park DS,Kim ML,et al .Clinical experiences of the levonorgestrel-releasing intrauterine system in Korean women with adenomyosis[J].Korean J Gynecol Endosc Minim Invasive Surg,2012,24(2):108-114. [2] Brueggmann D , Jaque JM , Lee AW et al. Expression of Wnt signaling pathway genes in human endometriosis tissue: a pilot study[J].Eur J Obstet Gynecol Reprod Biol,2016 ,199:214-215. [3] Abrao MS. Pillars for surgical treatment of bowel endometriosis[J].J Minim Invasive Gynecol,2016 , 23 (4 ):461-462. [4] Chene G. Endometriosis and ovarian cancer: An old story[J].Gynecol Obstet Fertil,2016 ,44(2):77-78 . [5] 姚艳,温兰玲,黄秀敏,等.536例采用IADPSG标准诊断妊娠期糖尿病患者的妊娠结局[J].中国妇幼保健,2014,29(20):3232-3236. [6] Prast J , Oppelt P , Shamiyeh A ,et al. Costs of endometriosis in Austria: a survey of direct and indirect costs[J].Arch Gynecol Obstet,2013 , 288 (3 ):569-576. [7] 崔欠欠,程玲慧,曹云霞,等.左炔诺孕酮宫内缓释系统治疗子宫内膜异位性疾病的临床观察[J].中国临床保健杂志,2015,18(1):76-78. [8] Heikinheimo O,Gemzell-Danielsson K.Emerging indications for the levonorgestrel-releasing intrauterine system (LNGIUS)[J].Acta Obstet Gynecol Scand,2012,91(1):3-9. [9] 张岩,杨飚,徐文萍,等.促性腺激素释放激素激动剂联合左炔诺孕酮宫内节育系统用于子宫内膜异位症术后效果[J].中国临床保健杂志,2016,19(4):389-392. [10] 李旭卿,陶丽娜,任洪叶,等.孕三烯酮与左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床疗效及安全性分析[J].医学临床研究,2017,34(1):46-48. [11] 李晓红,杜蓉,丁岩,等.左炔诺孕酮宫内缓释系统治疗子宫内膜异位症及子宫腺肌病的5年临床观察[J].实用医学杂志,2014,12(12):1938-1940.
2018, Vol. 35 
